T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$670M |
| 2 |
Martin Marietta Materials
MLM
|
+$496M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$462M |
| 4 |
Lam Research
LRCX
|
+$420M |
| 5 |
argenx
ARGX
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ingersoll Rand
IR
|
+$1.12B |
| 2 |
Xcel Energy
XEL
|
+$944M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$858M |
| 4 |
KKR & Co
KKR
|
+$572M |
| 5 |
Analog Devices
ADI
|
+$515M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.7% |
| 2 | Healthcare | 19.81% |
| 3 | Industrials | 12.92% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Financials | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Caterpillar
CAT
$394B
| – | – |
-517
| Closed | -$153K |
|
|
CHCT
627
Community Healthcare Trust
CHCT
$437M
| – | – |
-65,884
| Closed | -$1.76M |
|
628
Clarivate
CLVT
$1.19B
| – | – |
-6,968,706
| Closed | -$64.5M |
|
629
Copart
CPRT
$27.1B
| – | – |
-1,956
| Closed | -$96K |
|
630
Cintas
CTAS
$81.4B
| – | – |
-6,440
| Closed | -$971K |
|
|
EB
631
DELISTED
Eventbrite
EB
| – | – |
-663,876
| Closed | -$5.55M |
|
632
Emcor
EME
$37B
| – | – |
-341
| Closed | -$74K |
|
633
Edwards Lifesciences
EW
$53.8B
| – | – |
-1,249
| Closed | -$96K |
|
634
FIVE9
FIVN
$2.35B
| – | – |
-1,413,228
| Closed | -$111M |
|
635
Green Dot
GDOT
$767M
| – | – |
-3,957,203
| Closed | -$39.2M |
|
636
Guardant Health
GH
$21.9B
| – | – |
-1,010,326
| Closed | -$27.3M |
|
637
ICU Medical
ICUI
$4.51B
| – | – |
-442,403
| Closed | -$44.1M |
|
638
Kemper
KMPR
$1.57B
| – | – |
-248,366
| Closed | -$12.1M |
|
639
Kymera Therapeutics
KYMR
$9.47B
| – | – |
-1,295,943
| Closed | -$33M |
|
640
LKQ Corp
LKQ
$6.28B
| – | – |
-1,533
| Closed | -$74K |
|
|
CYPH
641
Cypherpunk Technologies Inc
CYPH
$70.1M
| – | – |
-35,400
| Closed | -$147K |
|
642
Main Street Capital
MAIN
$5.52B
| – | – |
-442,126
| Closed | -$19.1M |
|
643
Mobileye
MBLY
$7.59B
| – | – |
-8,928,746
| Closed | -$387M |
|
644
MGM Resorts International
MGM
$11.1B
| – | – |
-7,130,512
| Closed | -$319M |
|
645
McGrath RentCorp
MGRC
$2.96B
| – | – |
-506,941
| Closed | -$60.6M |
|
646
Myers Industries
MYE
$1.26B
| – | – |
-920,216
| Closed | -$18M |
|
647
NorthWestern Energy
NWE
$4.41B
| – | – |
-412,490
| Closed | -$21M |
|
|
NXRT
648
NexPoint Residential Trust
NXRT
$644M
| – | – |
-1,166,683
| Closed | -$40.2M |
|
649
Nexstar Media Group
NXST
$5.71B
| – | – |
-87,631
| Closed | -$13.7M |
|
650
Outset Medical
OM
$85M
| – | – |
-211,116
| Closed | -$17.1M |
|
Similar funds
T. Rowe Price Investment Management's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Investment Management held 669 positions worth $163B, up 6.3% from $154B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
T. Rowe Price Investment Management's Q1 2024 filing shows 73 new, 322 increased, 222 reduced and 49 closed positions. Its largest new stake was NiSource: 11,684,654 shares worth $323M. The largest sale was Ingersoll Rand, an estimated $1.12B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- T. Rowe Price Investment Management's largest Q1 2024 buy was NiSource: 11,684,654 shares worth $323M.
- T. Rowe Price Investment Management added most to Canadian Natural Resources in Q1 2024, an estimated $670M increase.
- T. Rowe Price Investment Management's biggest Q1 2024 reduction was Ingersoll Rand, cutting an estimated $1.12B.
- T. Rowe Price Investment Management fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $858M.
- T. Rowe Price Investment Management's ten largest holdings make up 15% of its $163B portfolio in Q1 2024.
- T. Rowe Price Investment Management opened 73 new positions and closed 49 in Q1 2024.
- T. Rowe Price Investment Management's portfolio value rose 6.3% quarter-over-quarter to $163B.
Based on T. Rowe Price Investment Management's 13F filing for Q1 2024, filed 15 May 2024.